Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Schizophrenia cognitive

T. Suto, M. Fukuda, M. Ito, T. Uehara, and M. Mikuni. Multichannel near-infrared spectroscopy in depression and schizophrenia Cognitive brain activation study. Biological Psychiatry, 55 501-511, 2004. [Pg.371]

T, Flaum M Defining the phenotype of schizophrenia cognitive dysmetria and its neural mechanisms. Biol. Psychiatry 1999 46 908-920. 40. [Pg.2289]

Kohler CG, Martin EA, Kujawski E, Bilker W, Gur RE, Gur RC (2007) No effect of donepezil on neurocognition and social cognition in young persons with stable schizophrenia. Cognit Neuropsychiatry 12 412-421. [Pg.157]

Emrich HM, Leweke EM, Schneider U. Towards a cannabinoid hypothesis of schizophrenia cognitive impairments due to dysregulation of the endogenous cannabinoid system. Pharmacol. Biochem. Behav. 56, 803-807 (1997). [Pg.282]

In summary, antipsychotic drugs have a significant impact on the acute resolution and the maintenance of remission of symptoms of schizophrenia, enabling focus on rehabilitation efforts directed at residual cognitive, social, and occupational disabilities. The... [Pg.184]

Evins AE, Mays VK, Rigotti NA, et al A pilot trial of bupropion added to cognitive behavioral therapy for smoking cessation in schizophrenia. Nicotine Tob Res 3 397-M03, 2001... [Pg.335]

The prefrontal cortex (PFQ and in particular the dorsal lateral part (DLPFQ appear to be particularly important in schizophrenia (Kerwin 1992). Lesions there are known to produce functional defects in humans reminiscent of many of the negative symptoms of schizophrenia, such as attention and cognitive defects and withdrawal. Despite this, no specific pathology is seen in the DLPFC in schizophrenics although there is some atrophy and neuronal loss which are normally old and could be congenital. That being so, it is necessary to explain why the symptoms become apparent only in adolescence. [Pg.356]

Recognize the signs and symptoms of schizophrenia and be able to distinguish among positive, negative, and cognitive symptoms of the illness. [Pg.549]

Green, M. F. Braff, D. L. (2001). Translating the basic and clinical cognitive neuroscience of schizophrenia to drug development and clinical trials of antipsychotic medications. Biol. [Pg.166]

Johnstone EC, Crow TJ, Frith CD, Stevens J and Kreel L (1976). Cerebral ventricular size and cognitive impairment in chronic schizophrenia. Lancet, 1, 924-926. [Pg.269]

See other pages where Schizophrenia cognitive is mentioned: [Pg.446]    [Pg.221]    [Pg.446]    [Pg.221]    [Pg.217]    [Pg.183]    [Pg.184]    [Pg.336]    [Pg.438]    [Pg.1125]    [Pg.264]    [Pg.324]    [Pg.357]    [Pg.61]    [Pg.549]    [Pg.551]    [Pg.551]    [Pg.552]    [Pg.554]    [Pg.72]    [Pg.184]    [Pg.5]    [Pg.15]    [Pg.74]    [Pg.75]    [Pg.98]    [Pg.153]    [Pg.154]    [Pg.156]    [Pg.156]    [Pg.157]    [Pg.157]    [Pg.162]    [Pg.163]    [Pg.184]    [Pg.221]    [Pg.334]   
See also in sourсe #XX -- [ Pg.370 , Pg.371 , Pg.374 , Pg.375 , Pg.375 , Pg.376 , Pg.377 ]



SEARCH



Cognitive dysfunction in schizophrenia

Cognitive function in schizophrenia

Cognitive impairment in schizophrenia

Schizophrenia cognitive dysfunction

Schizophrenia cognitive enhancers

Schizophrenia cognitive function

Schizophrenia cognitive impairment

© 2024 chempedia.info